CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442

S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE

6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL

Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Non-Nucleoside Inhibitors

High Resolution Structures of HIV-1 RT from Four RT-Inhibitor Complexes

The Structure of HIV-1 Reverse Transcriptase Complexed with 9-Chloro-TIBO: Lessons for Inhibitor Design

Crystals of HIV-1 Reverse Transcriptase Diffracting to 2.2 A Resolution

CRYSTAL WAS FLASH COOLED AND MAINTAINED AT 100K DURING DATA COLLECTION. ALL DATA WAS INCLUDED APART FROM OUTLIERS.

A COMBINED MODEL RT-NEVIRAPINE(1VRT) AND APO-RT(1RTJ)

HIV-1 REVERSE TRANSCRIPTASE, 6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL

NUCLEOTIDYLTRANSFERASE, HIV-1 REVERSE TRANSCRIPTASE